Phase II Trial of Hypofractionated Intensity Modulated Radiotherapy to 60 Gy in 10 Fractions with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme

被引:0
|
作者
Reddy, K. [1 ]
Damek, D. [1 ]
Gaspar, L. [1 ]
Ney, D. [1 ]
Kavanagh, B. [1 ]
Waziri, A. [1 ]
Lillehei, K. [1 ]
Stuhr, K. [1 ]
Chen, C. [1 ]
机构
[1] Univ Colorado, Aurora, CO USA
关键词
D O I
10.1016/j.ijrobp.2011.06.268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S130 / S130
页数:1
相关论文
共 50 条
  • [1] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Waziri, Allen
    Lillehei, Kevin
    Kleinschmidt-DeMasters, B. K.
    Robischon, Monica
    Stuhr, Kelly
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074
  • [2] Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
    Ammirati, Mario
    Chotai, Silky
    Newton, Herbert
    Lamki, Tarig
    Wei, Lai
    Grecula, John
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (04) : 633 - 637
  • [3] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [4] Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
    Reddy, Krishna
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Stuhr, Kelly
    Kavanagh, Brian D.
    Chen, Changhu
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 655 - 660
  • [5] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Ney, Douglas E.
    Carlson, Julie A.
    Damek, Denise M.
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Kleinschmidt-DeMasters, B. K.
    Waziri, Allen E.
    Lillehei, Kevin O.
    Reddy, Krishna
    Chen, Changhu
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 135 - 143
  • [6] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E. Ney
    Julie A. Carlson
    Denise M. Damek
    Laurie E. Gaspar
    Brian D. Kavanagh
    B. K. Kleinschmidt-DeMasters
    Allen E. Waziri
    Kevin O. Lillehei
    Krishna Reddy
    Changhu Chen
    [J]. Journal of Neuro-Oncology, 2015, 122 : 135 - 143
  • [7] Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme
    Reddy, Krishna
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Chen, Changhu
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (06) : 714 - 721
  • [8] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    [J]. Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [9] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [10] PATTERNS OF FAILURE IN PATIENTS WITH GLIOBLASTOMA TREATED WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY AND TEMOZOLOMIDE ON A PHASE II TRIAL
    Reddy, Krishna
    Damek, Denise
    Gaspar, Laurie
    Ney, Douglas
    Kavanagh, Brian
    Waziri, Allen
    Lillehei, Kevin
    Stuhr, Kelly
    Chen, Changhu
    [J]. NEURO-ONCOLOGY, 2012, 14 : 140 - 140